Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 151 - 160 of 169

Selected Filters:
10 October 2019

Social Harms and Use of the Dapivirine Vaginal Ring

The dapivirine ring and other woman-initiated HIV prevention methods are designed to enable women to have more control over their sexual health and risk of HIV exposure, but research has revealed that women's male partners often influence their ability to use these methods. This brief summarizes an analysis of MTN-020/ASPIRE trial data, which showed that…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Tanzania Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Tanzania was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Malawi Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Malawi was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Zimbabwe Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Zimbabwe was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Kenya Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Kenya was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Uganda Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Uganda was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Rwanda Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Rwanda was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…

Research

Document
8 April 2019

Dapivirine Ring Early Introduction Considerations — Seven Country Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Rwanda, Uganda, Kenya, Zimbabwe, Malawi, Tanzania and South Africa were prioritized for analysis due to the state of the HIV epidemic in…

Research

Document
6 February 2019

The Landscape For End User Research: Mapping and Findings

The HIV Prevention Market Manager undertook an effort to map the landscape of ongoing and planned work on bringing HIV prevention to adolescent girls and young women and other populations in sub-Saharan Africa. This document provides a summary and analysis of the end-user projects and studies underway. This information can be used to inform collaborations…

Demand Creation/Marketing, Research, Service Delivery

Document
31 January 2019

Dapivirine Ring: The case for action

A 2017 report that lays out next steps for the ring as it nears a regulatory decision and the field prepares for product introduction.

Community/Advocacy

Document